- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05786209
A Study of a Whole-Body Balm on Newborn Babies
March 11, 2024 updated by: Johnson & Johnson Consumer Inc. (J&JCI)
A Single-Center, Four Week Usage Clinical Study to Evaluate the Tolerance and Efficacy of a Whole-Body Balm on Newborn Babies
The purpose of this study is to evaluate the skin tolerance, instrumental efficacy, and perceived product efficacy of a whole-body balm on newborns (0-28 days old).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84107
- CenExcel JBR
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 second to 4 weeks (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Newborn participants only:
- Male or Female
- 0 to 3 months old, targeting at least 15 subjects in the 0 - 28 days age range at time of enrollment.
- Has Parent Participant-reported Natural Skin tone/skin Color As Follows, including: (a) Skin tones "Pale/fair to light white" and/or "White to light beige" approximately 10 participants; (b) Skin tones "Beige to light tan/light olive" and/or "Medium tan/medium olive to light brown" approximately 10 participants; (c) Skin tones "Medium brown to dark brown" and/or "Darkest brown to darkest black" approximately 10 participants
- Full term (37 plus weeks of gestation, both vaginal and Caesarean mode of delivery can be included) newborn
Newborn participant and parent participant:
- Generally, in good health based on medical history reported by the parent participant
Parent participant only:
- Able to read, write, speak, and understand English
- At least 18 years old and is the parent (adoptive or biological), legal guardian, and primary caregiver of the newborn participant
- Has signed the informed consent document (ICD) including Health Insurance Portability and Accountability Act (HIPAA) disclosure
- Intends to complete the study and is willing and able to follow all study instructions
Exclusion Criteria:
Newborn participant only:
- Presents with a skin condition that may influence the outcome of the study or increase risk to the newborn participant (example , psoriasis, eczema, atopic dermatitis, cutaneous xerosis, erythema, or active skin cancer)
- Has a family history of (defined as having a biological parent or full sibling with) eczema/atopic dermatitis
- Has been bathed within 3 hours prior to Visit 1
- Has a clinical grade greater than 0 for rash/irritation, or greater than or equal to 1 for any of the other clinically assessed tolerance parameters at Visit 1
Newborn participant and parent participant:
- Has known allergies or adverse reactions to common topical skincare products
- Has self-reported (for the parent participant) or parent participant reported (for the newborn participant) Type 1 or Type 2 diabetes or is taking insulin or another anti-diabetic medication
- Is taking a medication that would mask an AE or confound the study results, including (a) Immunosuppressive or steroidal drugs within 3 months before Visit 1; (b) Non-steroidal anti-inflammatory drugs within 5 days before Visit 1; (C) Antihistamines within 2 weeks (14 days) before Visit 1
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Whole-body Balm + Wash and Shampoo
Parent participant will be instructed to apply the whole-body balm on the newborn baby's whole body (excluding the mouth, eyes, diaper area, and scalp) two times per day (morning and evening), and to cleanse the newborn baby with the wash and shampoo at least once per week and no more than three times per week up to Day 28.
|
Balm will be applied to cover newborn's entire body (while avoiding the mouth, eyes, diaper area, and scalp), and gently massaged onto the skin until the balm is fully absorbed.
Wash and shampoo will be used to cleanse newborn baby using an "in tub" bathing method.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline After 4 Weeks of Product Use in Clinical and Parental Evaluations of Skin tolerance Measures
Time Frame: Change from baseline after 4 weeks
|
Change from baseline after 4 weeks of product use in clinical and parental evaluations of skin tolerance measures will be reported.
The clinical and parental evaluations of tolerance will be recorded on paper source documentation.
|
Change from baseline after 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline After 7 Days of Product Use in Clinical and Parental Evaluations of Skin Tolerance Measures
Time Frame: Change from baseline after 7 days
|
Change from baseline after 7 days of product use in clinical and parental evaluations of skin tolerance measures will be reported.
The clinical and parental evaluations of tolerance will be recorded on paper source documentation.
|
Change from baseline after 7 days
|
Change From Baseline After 7 Days of Product Use in Corneometer and Transepidermal Water Loss (TEWL) Measurements
Time Frame: Change from baseline after 7 days
|
Change from baseline after 7 days of product use in Corneometer and TEWL measurements will be reported.
The Corneometer measures moisture content in the stratum corneum by an electrical capacitance method.
Readings are proportional to the dielectric constant of the surface layers of the skin, and the results are displayed in arbitrary "Corneometer units" ranging from 0 to 120, with increasing values corresponding to more hydrated skin.
TEWL is a equipment with open chamber TEWL probes to measure the TEWL of the skin.
The non-invasive probe contains two sensors that measure the temperature and relative humidity at two fixed points along the axis normal to the skin surface.
|
Change from baseline after 7 days
|
Change From Baseline After 4 Weeks of Product Use in Corneometer and Transepidermal Water Loss (TEWL) Measurements
Time Frame: Change from baseline after 4 weeks
|
Change from baseline after 4 weeks of product use in Corneometer and TEWL measurements will be reported.
The Corneometer measures moisture content in the stratum corneum by an electrical capacitance method.
Readings are proportional to the dielectric constant of the surface layers of the skin, and the results are displayed in arbitrary "Corneometer units" ranging from 0 to 120, with increasing values corresponding to more hydrated skin.
TEWL is a equipment with open chamber TEWL probes to measure the TEWL of the skin.
The non-invasive probe contains two sensors that measure the temperature and relative humidity at two fixed points along the axis normal to the skin surface.
|
Change from baseline after 4 weeks
|
Number of Response Options for Each Question in the Parental Questionnaire
Time Frame: Day 28
|
Number of response options for each question in the parental questionnaire will be reported.
Parental questionnaire will be completed by the parent participants which include the questions about "how much do you agree after using balm" where 1 indicates 'strongly disagree', 2 indicates 'somewhat disagree', 3 indicates ;neither agree or disagree', 4 indicates 'somewhat agree', 5 indicates 'strongly agree'.
|
Day 28
|
Percentage of All Response Options for Each Question in the Parental Questionnaire
Time Frame: Day 28
|
Percentage of all response options for each question in the parental questionnaire will be reported.
parental questionnaire will be completed by the parent participants which include the questions about "how much do you agree after using balm" where 1 indicates 'strongly disagree', 2 indicates 'somewhat disagree', 3 indicates ;neither agree or disagree', 4 indicates 'somewhat agree', 5 indicates 'strongly agree'.
|
Day 28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Todd Bertoch, M.D., Cenexel JBR
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- https://www.courage-khazaka.de/en/scientific-products/all-products/16-wissenschaftliche-produkte/alle-produkte/183-corneometer-e.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 27, 2023
Primary Completion (Actual)
October 6, 2023
Study Completion (Actual)
October 6, 2023
Study Registration Dates
First Submitted
March 15, 2023
First Submitted That Met QC Criteria
March 15, 2023
First Posted (Actual)
March 27, 2023
Study Record Updates
Last Update Posted (Actual)
March 13, 2024
Last Update Submitted That Met QC Criteria
March 11, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- CCSSKB005124 (Other Identifier: Johnson & Johnson Consumer Inc. (J&JCI))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Johnson & Johnson Consumer Inc. has an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health.
Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Whole-body Balm
-
The Hong Kong Polytechnic UniversityCompleted
-
Gazi UniversityGulhane Training and Research HospitalRecruitingArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
Federal University of Health Science of Porto AlegreCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
The Hong Kong Polytechnic UniversityUnknown
-
Federal University of Health Science of Porto AlegreNot yet recruiting
-
Federal University of Health Science of Porto AlegreLeonhardt Ventures LLCNot yet recruiting
-
University of ZurichRecruiting
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical University; Children's Hospital of... and other collaboratorsWithdrawnBrain Injury | Hypoxic- Ischemic Encephalopathy | Whole-Body HypothermiaChina
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany